Therefore, the lower serum albumin concentrations in patients with AD/ACLF compared with OPDs (p <0.05, Supplementary Table S1A) indicated that less of the total PGE2 measured was albumin bound and, consequently, more unbound, bioavailable PGE2 was present in these patients. This evidence concerns the gene ALB and Alzheimer disease.